News from the World of Clinical Research

Gilead's remdesivir looks promising in leaked early results, but don't jump to conclusions: analysts

The world is watching and waiting for data to see whether Gilead Sciences' investigational antiviral remdesivir can help fight COVID-19. And while some leaked early results suggest that it can, indust…

WHO recommended disinfectants are easy to make and effective against COVID-19

When used correctly, both alcohol-based hand disinfectants recommended by the World Health Organization (WHO) are effective against the novel coronavirus Sars-Cov-2, as confirmed by an international r…

Nationwide launch for GP-based trial of COVID-19 therapies

As of this morning – Monday April 20 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 120,067 with 16,060 deaths.

Researchers from Oxford University have begun recruiting…

A guide to clinical trials disrupted by the coronavirus pandemic

The coronavirus has upended the globe. Cities and countries have enacted shelter-in-place policies, shuttering businesses while canceling school and other events. Many companies have sent their employ…

Individual genetic variation in immune system may affect severity of COVID-19

Genetic variability in the human immune system may affect susceptibility to, and severity of infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the co…

COVID-19 Statement from the ICR Secretariat

ICR Membership Announcement
21.04.2020

The Institute of Clinical Research (ICR) has been closely monitoring Government advice and updates on the spread of Covid-19. In line with Government guidance, th…

AstraZeneca and Merck drug wins approval for rare cancer after failing elsewhere

The Food and Drug Administration approved AstraZeneca and Merck & Co.'s drug selumetinib to treat neurofibromatosis type 1, or NF1, a rare and typically inherited disease that causes tumors to gro…

Commission postpones application of the Medical Devices Regulation to prioritise the fight against coronavirus

Today, the European Commission has adopted a proposal to postpone by one year the date of application of the Medical Devices Regulation to allow Member States, health institutions and economic operato…

Early data on Gilead coronavirus drug raises hope, but answers few questions

Three dozen patients with COVID-19 given an experimental Gilead drug called remdesivir appeared to improve in the days following treatment, raising some hope the antiviral therapy could prove benefici…